Biotech Stock News (LXRX) (BIOC) (LLY) (AMGN) (AQXP)

Lexicon Pharmaceuticals (NASDAQ:LXRX)  On August 3, 2015 shares of Lexicon Pharmaceuticals were up 61% after the company posted positive phase 3 Results in Patients with Carcinoid Syndrome. Carcinoid Syndrome occurs when a carcinoid tumor advances to a later stage. Typically this disease targets the lining of the lungs or stomach of the patient and has … Read more

Lexicon Pharmaceuticals (LXRX): Down But Not For Long

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Lexicon Pharmaceuticals is having a rough day in the market today. However, I don’t think that the declines are likely to last. The reality is that the company released incredibly positive data with regard to a phase 3 test of an experimental drug yesterday; which will likely prove to be … Read more